Search Results 721-730 of 17075 for EBV
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
About this study. The aim of this research is to look at two conditions, Essential Thrombocythemia (ET) and Polycythemia Vera (PV).
The purpose of this study is to determine change in disease symptoms of ABBV-383 compared to standard available therapies in adult participants with Relapsed or ...
Mayo Clinic is again top-ranked in more specialties than any other hospital and has two hospitals recognized as Honor Roll members — the highest honor — in ...
The purpose of this study is to evaluate circulating tumor DNA as a potential biomarker for pre-surgery treatment response in patients who have esophageal ...
Early Life Immune Responses: Kathryn A. Knoop · Early-Onset Parkinson's Disease and Synucleinopathies: Rodolfo Savica · Elbow: Shawn W. O'Driscoll · Epigenetic ...
A Study Comparing 177Lu-DOTA0-Tyr3-Octreotate to Octreotide LAR to Treat Patients with Inoperable, Progressive, Somatostatin Receptor Positive Midgut Carcinoid ...
The purpose of this study is to evaluate the safety, tolerability, and preliminary effectiveness of HMPL-306 in advanced or metastatic solid tumors with IDH ...
Seek immediate medical care if: Your eyesight changes suddenly. Red eye happens with a bad headache, eye pain, fever or if light starts to hurt your eyes.
This study will compare the effectiveness of best available surgical treatment with best available endovascular treatment in adults with critical limb ischemia ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.